http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2219605-C
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_94ff2d78578d95d1e8d3a2233c76188d |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-366 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-366 |
| filingDate | 1997-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2002-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5ed620092ba45e15d8739db4b355e142 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_88c1314aecf0a2d207442f1df0157900 |
| publicationDate | 2002-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CA-2219605-C |
| titleOfInvention | Method of stimulating gastrointestinal motility with ellagic acid |
| abstract | The present invention relates to the use of ellagic acid for the treatment of gastrointestinal disorders by stimulating the motility of the GI tract. In particular the present invention relates to a method of treatment of constipation, heartburn, non ulcer dyspepsia, GERD, and/or esophagitis, with a pharmaceutical composition comprising a safe and effective amount of ellagic acid or pharmaceutically acceptable salts or esters thereof. Preferably the ellagic acid is administered perorally. |
| priorityDate | 1996-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 118.